Sangamo Therapeutics announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease

Click here to view

Presentation

Poster: Epigenetic Regulation of Human Prion Expression as a Potential One-Time Treatment for Prion Disease

Download PDF